Cytocom Inc. sell Midas
Start price
18.02.21
/
50%
€9.20
Target price
18.02.22
-
Performance (%)
-68.91%
End price
29.08.21
€2.86
Summary
This prediction ended on 29.08.21 with a price of €2.86. The SELL prediction by Midas for Cytocom Inc. performed very well with a performance of -68.91%. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytocom Inc. | - | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% | 51.689% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% | 67.992% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% | 57.109% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% | 58.872% |
Comments by Midas for this prediction
In the thread Cytocom Inc. diskutieren
Sell Cleveland Biolabs